Cusic Inc.
USPTO PatentsView assignee record - 8 granted patents across 4 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: H01L (Semiconductor Devices NOT Covered BY Class H10).
The verdict
According to USPTO PatentsView, Cusic ranks #31,335 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 4 technology areas.
- #31,335
- of 49,997 US assignees by volume
- 11th percentile
- by Innovation Score (22.7/100)
- 9.6
- avg claims per patent
- +600%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R31335 · Foreign Corporation #31,335 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 8 grants
- MID-PACK #31,335/49,997
- PHOTO-FINISH CTI Biopharma
- CPC-NARROW H01L · 4 areas
- INNOV-THIN 22.7/100
- CLAIMS-PAR 9.6 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +600% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: CTI Biopharma Corp. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Cusic’s 22.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Cusic
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Cusic · this assignee 23
Cusic · this assignee
23 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Cusic's Innovation Score is 22.7/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Cusic?
Each dot is one of Cusic’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Cusic’s own 9.6 claims/patent is at or below the 18.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Cusic's grants concentrate
Cusic Inc. is a focused PatentsView assignee: 4 CPC subclasses with 87.5% of grants classified under H01L (Semiconductor Devices NOT Covered BY Class H10). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2019. By volume, Cusic sits between CTI Biopharma Corp. and Cybertoka Ltd..
Cusic's three-year grant acceleration
Cusic Inc. shows 2 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Cusic's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- CTI Biopharma
CTI Biopharma Corp.
8 patents
- Ctrl-labs
CTRL-labs Corporation
8 patents
- Cubic Tech
Cubic Tech Corporation
8 patents
- Curv Brands
Curv Brands, LLC
8 patents
- Cutting Edge Spine
Cutting Edge Spine LLC
8 patents
- CY Cergy Paris Un…
CY Cergy Paris Universite
8 patents
- CY Vision
CY Vision Inc.
8 patents
- Cybertoka
Cybertoka Ltd.
8 patents
- Cusic ◀
Cusic Inc.
8 patents
What this shows Cusic holds 8 patents at rank #31,234, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Cusic
By rank, the assignees closest to #31,234 in granted patent volume.
- CTI Biopharma Corp. #31,230 · 8 patents
- CTRL-labs Corporation #31,231 · 8 patents
- Cubic Tech Corporation #31,232 · 8 patents
- Curv Brands, LLC #31,233 · 8 patents
- Cutting Edge Spine LLC #31,235 · 8 patents
- CY Cergy Paris Universite #31,236 · 8 patents
- CY Vision Inc. #31,237 · 8 patents
- Cybertoka Ltd. #31,238 · 8 patents
Leaders in H01L (Semiconductor Devices NOT Covered BY Class H10)
Other assignees with the most granted patents in Cusic's primary technology class.
- Taiwan Semiconductor Manufacturing Company Ltd. 19,657 in class
- Samsung Electronics Co., Ltd. 10,662 in class
- International Business Machines Corporation 7,298 in class
- Applied Materials, Inc. 4,095 in class
- Intel Corporation 4,089 in class
- Tokyo Electron Limited 3,737 in class
- Micron Technology, Inc. 3,107 in class
- GlobalFoundries Inc. 2,756 in class
Cusic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
23 11th percentile higher than 11% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 12.5% |
| 2020 | 3 | 37.5% |
| 2021 | 2 | 25.0% |
| 2022 | 1 | 12.5% |
| 2024 | 1 | 12.5% |
Which technologies does Cusic Inc. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Cusic Inc.'s patent record in context - here's where to go next.
- Cusic Inc.'s lead technology class is H01L (Semiconductor Devices NOT Covered BY Class H10), 87.5% of its portfolio - see every assignee active in that class. Explore H01L
- Ranked #31,335 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Cusic Inc. against CTI Biopharma Corp., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 22.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.